CIK 0001711754
- Non-accelerated filer
- Smaller reporting company
Inmune Bio, Inc.
Sign in to watch- Ticker
- INMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 475205835
- Phone
- +1 858-964-3720
- Business address
- 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
- 4 Open-market sale Director sold 10,000 shares at $11.95 ($119,496)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 220,000 shares at $4.60 ($1,012,000)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Scientific Officer bought 2,918 shares at $6.23 ($18,179)
- 4 Open-market buy Director bought 5,000 shares at $6.00 ($30,000)
- 4 Open-market buy CFO, Treasurer & Secretary bought 3,000 shares at $5.65 ($16,950)
Page 6 of 8 · 142 filings